112 results on '"Liggett W"'
Search Results
2. On the Asymptotic Optimality of Spectral Analysis for Testing Hypotheses About Time Series
3. Purification of macrolide 2′-phosphotransferase fromStreptomyces coelicolor Müller
4. Obstetrics In General Practice
5. Formation and mechanism of action of leukotrienes: enzymatic hydration of leukotriene A4 by human blood cells
6. Abstract P4-22-09: A phase 2 open label study of everolimus in combination with endocrine therapy in resistant hormone receptor-positive HER2-negative advanced breast cancer
7. Changing cost management at The Johns Hopkins University Applied Physics Laboratory: Morphing pushback into acceptance
8. P3-14-29: Neoadjuvant Sunitinib Administered with Weekly Paclitaxel/Carboplatin in Patients with Locally Advanced Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial.
9. ChemInform Abstract: Production, Isolation, and Identification of Dihydroepiepoformin as an IL-1 Receptor Antagonistic Component in Penicillium patulum.
10. ChemInform Abstract: Microbiological Oxygenation of Bridgehead Azabicycloalkanes.
11. Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by maintenance bevacizumab (B) in the treatment (tx) of limited-stage small cell lung cancer (LS-SCLC): Update of a phase II trial of the Minnie Pearl Cancer Research Network
12. Topotecan—Single agent activity in a weekly intravenous (IV) schedule for first-line therapy in poor prognosis extensive stage small cell lung cancer (SCLC): A Minnie Pearl Cancer Research Network phase II trial
13. Phase II pilot trial of imatinib mesylate with weekly docetaxel in metastatic breast cancer
14. Fludarabine/rituximab (FR) followed by alemtuzumab as first-line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL): A Minnie Pearl Cancer Research Network phase II trial
15. Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by bevacizumab (B) in the treatment of limited-stage small cell lung cancer (SCLC): A phase II trial of the Minnie Pearl Cancer Research Network
16. Design of a Mission Operations Center at the Johns Hopkins University Applied Physics Laboratory.
17. Review of material provided by EPA on the analysis for organic chemicals in the EPA Love Canal monitoring study
18. Evaluation and compilation of DOE waste package test data: Biannual report, February 1987--July 1987
19. Role of the p16 tumor suppressor gene in cancer.
20. ChemInform Abstract: Microbiological Oxygenation of 1‐Azidoadamantane and of N‐Benzoyl‐3‐ noradamantanamine.
21. The Effect of Pool Diameter on the Property of Smoke Produced by Crude Oil Fires
22. The effect of pool diameter on the properties of smoke produced by crude oil fires
23. Effects of macrophage colony stimulating factor and granulocyte‐macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells
24. Tests of the Recalibration Period of a Drifting Instrument.
25. Purification of lincosaminide O-nucleotidyltransferase from Streptomyces coelicolor Mueller.
26. Effects of trospectomycin on serum sensitivity of Escherichia coli UC 9451
27. Interlaboratory comparison of actinides in human tissue239Pu and240Pu
28. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.
29. Geometrical alignment errors in the measurement of prismatic retroreflectors.
30. Aerospace Capability and Systems Analysis Applied to Urban Problems - Some Views from a Social Scientist.
31. Covariance of Noise in Attenuating Media.
32. Passive Sonar Processing for Noise with Unknown Covariance Structure.
33. Noise Covariance and Vertical Directivity in a Deep Ocean.
34. Covariance of Surface-Generated Noise in a Deep Ocean.
35. Interlaboratory comparison of actinides in human tissue239Pu and240Pu
36. Albumin-eicosanoid interactions. A model system to determine their attributes and inhibition.
37. Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry.
38. Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4.
39. Low-level radioactivity ocean sediment standard reference material
40. Development of the Automated Dynamic Model for the Integrated Facilities Requirements Study (IFRS). Volume III. Dynamic Model Programmer's Manual.
41. Development of the Optimization Model for the Integrated Facilities Requirements Study (IFRS) Phase III. Volume II. Formulation and Use of the IFRS Optimization Model.
42. The Integrated Facilities Requirements Study (IFRS) Phase III. Volume II. Phase III Changes to User's and Programmer's Manuals.
43. Development of the Optimization Model for the Integrated Facilities Requirements Study (IFRS) Phase III. Volume I. Summary of the Optimization Model.
44. Development of the Automated Dynamic Model for the Integrated Facilities Requirements Study (IFRS). Volume II. Dynamic Model User's Manual.
45. Development of the Fleet Air Readiness Training Model for the Integrated Facilities Requirements Study (IFRS) Phase III. Volume I. Summary of the Fleet Readiness Training (FRT) Management Planning Tool.
46. Development of the Automated Dynamic Model for the Integrated Facilities Requirements Study (IFRS). Volume I. Summary of the Dynamic Management Planning Tool.
47. Development of the Fleet Air Readiness Training Model for the Integrated Facilities Requirements Study (IFRS Phase III. Volume III. FRT User's Manual.
48. Development of the Fleet Air Readiness Training Model for the Integrated Facilities Requirements Study (IFRS) Phase III. Volume IV. FRT Programmer's Manual Readiness Training (FRT) Management Planning Tool.
49. The Integrated Facilities Requirements Study (IFRS) Phase III. Volume I. Summary.
50. Microbial O-phosphorylation of macrolide antibiotics.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.